HIV  ||| S:0 E:4 ||| NNP
stigma  ||| S:4 E:11 ||| NN
intervention  ||| S:11 E:24 ||| NN
in  ||| S:24 E:27 ||| IN
a  ||| S:27 E:29 ||| DT
low-HIV  ||| S:29 E:37 ||| JJ
prevalence  ||| S:37 E:48 ||| JJ
setting ||| S:48 E:55 ||| NN
:  ||| S:55 E:57 ||| :
a  ||| S:57 E:59 ||| DT
pilot  ||| S:59 E:65 ||| NN
study  ||| S:65 E:71 ||| NN
in  ||| S:71 E:74 ||| IN
an  ||| S:74 E:77 ||| DT
Egyptian  ||| S:77 E:86 ||| JJ
healthcare  ||| S:86 E:97 ||| JJ
facility  ||| S:97 E:106 ||| NN
This  ||| S:106 E:111 ||| DT
pilot  ||| S:111 E:117 ||| NN
study  ||| S:117 E:123 ||| NN
is  ||| S:123 E:126 ||| VBZ
the  ||| S:126 E:130 ||| DT
first  ||| S:130 E:136 ||| JJ
to  ||| S:136 E:139 ||| TO
evaluate  ||| S:139 E:148 ||| VB
stigma-reduction  ||| S:148 E:165 ||| JJ
intervention  ||| S:165 E:178 ||| NN
in  ||| S:178 E:181 ||| IN
a  ||| S:181 E:183 ||| DT
healthcare  ||| S:183 E:194 ||| JJ
setting  ||| S:194 E:202 ||| NN
in  ||| S:202 E:205 ||| IN
Egypt  ||| S:205 E:211 ||| NNP
and  ||| S:211 E:215 ||| CC
in  ||| S:215 E:218 ||| IN
the  ||| S:218 E:222 ||| DT
Middle  ||| S:222 E:229 ||| NNP
East  ||| S:229 E:234 ||| NNP
and  ||| S:234 E:238 ||| CC
North  ||| S:238 E:244 ||| NNP
Africa  ||| S:244 E:251 ||| NNP
region ||| S:251 E:257 ||| NN
.  ||| S:257 E:259 ||| .
It  ||| S:259 E:262 ||| PRP
also  ||| S:262 E:267 ||| RB
contributes  ||| S:267 E:279 ||| VBZ
to  ||| S:279 E:282 ||| TO
knowledge  ||| S:282 E:292 ||| NN
on  ||| S:292 E:295 ||| IN
how  ||| S:295 E:299 ||| WRB
to  ||| S:299 E:302 ||| TO
address  ||| S:302 E:310 ||| VB
stigma  ||| S:310 E:317 ||| NN
in  ||| S:317 E:320 ||| IN
low-HIV  ||| S:320 E:328 ||| JJ
prevalence  ||| S:328 E:339 ||| JJ
settings ||| S:339 E:347 ||| NNS
.  ||| S:347 E:349 ||| .
A  ||| S:349 E:351 ||| DT
quasi-experimental  ||| S:351 E:370 ||| JJ
study  ||| S:370 E:376 ||| NN
design  ||| S:376 E:383 ||| NN
was  ||| S:383 E:387 ||| VBD
used  ||| S:387 E:392 ||| VBN
to  ||| S:392 E:395 ||| TO
evaluate  ||| S:395 E:404 ||| VB
the  ||| S:404 E:408 ||| DT
effect  ||| S:408 E:415 ||| NN
of  ||| S:415 E:418 ||| IN
anti-HIV  ||| S:418 E:427 ||| JJ
stigma  ||| S:427 E:434 ||| NN
intervention  ||| S:434 E:447 ||| NN
in  ||| S:447 E:450 ||| IN
one  ||| S:450 E:454 ||| CD
hospital  ||| S:454 E:463 ||| NN
in  ||| S:463 E:466 ||| IN
Egypt ||| S:466 E:471 ||| NNP
.  ||| S:471 E:473 ||| .
A  ||| S:473 E:475 ||| DT
control  ||| S:475 E:483 ||| NN
hospital  ||| S:483 E:492 ||| NN
was  ||| S:492 E:496 ||| VBD
selected  ||| S:496 E:505 ||| VBN
and  ||| S:505 E:509 ||| CC
matched  ||| S:509 E:517 ||| VBN
to  ||| S:517 E:520 ||| TO
the  ||| S:520 E:524 ||| DT
intervention  ||| S:524 E:537 ||| NN
hospital  ||| S:537 E:546 ||| NN
by  ||| S:546 E:549 ||| IN
type ||| S:549 E:553 ||| NN
,  ||| S:553 E:555 ||| ,
size  ||| S:555 E:560 ||| NN
and  ||| S:560 E:564 ||| CC
location ||| S:564 E:572 ||| NN
.  ||| S:572 E:574 ||| .
The  ||| S:574 E:578 ||| DT
intervention  ||| S:578 E:591 ||| NN
focused  ||| S:591 E:599 ||| VBN
on  ||| S:599 E:602 ||| IN
HIV-related  ||| S:602 E:614 ||| JJ
stigma ||| S:614 E:620 ||| NN
,  ||| S:620 E:622 ||| ,
infection  ||| S:622 E:632 ||| NN
control  ||| S:632 E:640 ||| NN
and  ||| S:640 E:644 ||| CC
medical  ||| S:644 E:652 ||| JJ
ethics ||| S:652 E:658 ||| NNS
.  ||| S:658 E:660 ||| .
Stigma  ||| S:660 E:667 ||| NNP
was  ||| S:667 E:671 ||| VBD
measured  ||| S:671 E:680 ||| VBN
at  ||| S:680 E:683 ||| IN
baseline  ||| S:683 E:692 ||| NN
and  ||| S:692 E:696 ||| CC
at  ||| S:696 E:699 ||| IN
three  ||| S:699 E:705 ||| CD
months  ||| S:705 E:712 ||| NNS
post-intervention ||| S:712 E:729 ||| JJ
.  ||| S:729 E:731 ||| .
A  ||| S:731 E:733 ||| DT
standardized ||| S:733 E:745 ||| JJ
,  ||| S:745 E:747 ||| ,
10-point  ||| S:747 E:756 ||| JJ
scale  ||| S:756 E:762 ||| NN
was  ||| S:762 E:766 ||| VBD
developed  ||| S:766 E:776 ||| VBN
to  ||| S:776 E:779 ||| TO
measure  ||| S:779 E:787 ||| VB
stigmatizing  ||| S:787 E:800 ||| JJ
attitudes  ||| S:800 E:810 ||| NNS
and  ||| S:810 E:814 ||| CC
fear-based  ||| S:814 E:825 ||| JJ
stigma  ||| S:825 E:832 ||| NN
among  ||| S:832 E:838 ||| IN
participants ||| S:838 E:850 ||| NNS
.  ||| S:850 E:852 ||| .
Comparisons  ||| S:852 E:864 ||| NNS
of  ||| S:864 E:867 ||| IN
overall  ||| S:867 E:875 ||| JJ
and  ||| S:875 E:879 ||| CC
job-stratified  ||| S:879 E:894 ||| JJ
stigma  ||| S:894 E:901 ||| NN
scores  ||| S:901 E:908 ||| NNS
were  ||| S:908 E:913 ||| VBD
made  ||| S:913 E:918 ||| VBN
across  ||| S:918 E:925 ||| IN
the  ||| S:925 E:929 ||| DT
intervention  ||| S:929 E:942 ||| NN
and  ||| S:942 E:946 ||| CC
control  ||| S:946 E:954 ||| NN
hospitals ||| S:954 E:963 ||| NNS
,  ||| S:963 E:965 ||| ,
before  ||| S:965 E:972 ||| RB
and  ||| S:972 E:976 ||| CC
after  ||| S:976 E:982 ||| IN
the  ||| S:982 E:986 ||| DT
intervention ||| S:986 E:998 ||| NN
,  ||| S:998 E:1000 ||| ,
using  ||| S:1000 E:1006 ||| VBG
two-sample  ||| S:1006 E:1017 ||| JJ
t-test  ||| S:1017 E:1024 ||| JJ
and  ||| S:1024 E:1028 ||| CC
multivariate  ||| S:1028 E:1041 ||| JJ
regression  ||| S:1041 E:1052 ||| JJ
analysis ||| S:1052 E:1060 ||| NN
.  ||| S:1060 E:1062 ||| .
Mean  ||| S:1062 E:1067 ||| JJ
stigma  ||| S:1067 E:1074 ||| NN
scores  ||| S:1074 E:1081 ||| NNS
did  ||| S:1081 E:1085 ||| VBD
not  ||| S:1085 E:1089 ||| RB
reveal  ||| S:1089 E:1096 ||| VB
significant  ||| S:1096 E:1108 ||| JJ
differences  ||| S:1108 E:1120 ||| NNS
between  ||| S:1120 E:1128 ||| IN
the  ||| S:1128 E:1132 ||| DT
intervention  ||| S:1132 E:1145 ||| NN
and  ||| S:1145 E:1149 ||| CC
control  ||| S:1149 E:1157 ||| NN
hospitals  ||| S:1157 E:1167 ||| NNS
at  ||| S:1167 E:1170 ||| IN
baseline ||| S:1170 E:1178 ||| NN
.  ||| S:1178 E:1180 ||| .
After  ||| S:1180 E:1186 ||| IN
intervention ||| S:1186 E:1198 ||| NN
,  ||| S:1198 E:1200 ||| ,
the  ||| S:1200 E:1204 ||| DT
overall  ||| S:1204 E:1212 ||| JJ
value-based  ||| S:1212 E:1224 ||| JJ
and  ||| S:1224 E:1228 ||| CC
fear-based  ||| S:1228 E:1239 ||| JJ
stigma  ||| S:1239 E:1246 ||| NN
scores  ||| S:1246 E:1253 ||| NNS
were  ||| S:1253 E:1258 ||| VBD
significantly  ||| S:1258 E:1272 ||| RB
lower  ||| S:1272 E:1278 ||| JJR
in  ||| S:1278 E:1281 ||| IN
the  ||| S:1281 E:1285 ||| DT
intervention  ||| S:1285 E:1298 ||| NN
hospital  ||| S:1298 E:1307 ||| NN
compared  ||| S:1307 E:1316 ||| VBN
to  ||| S:1316 E:1319 ||| TO
the  ||| S:1319 E:1323 ||| DT
control  ||| S:1323 E:1331 ||| NN
hospital  ||| S:1331 E:1340 ||| NN
( ||| S:1340 E:1341 ||| -LRB-
2.1  ||| S:1341 E:1345 ||| CD
and  ||| S:1345 E:1349 ||| CC
1.1  ||| S:1349 E:1353 ||| CD
compared  ||| S:1353 E:1362 ||| VBN
to  ||| S:1362 E:1365 ||| TO
3.8  ||| S:1365 E:1369 ||| CD
and  ||| S:1369 E:1373 ||| CC
3.2 ||| S:1373 E:1376 ||| CD
,  ||| S:1376 E:1378 ||| ,
respectively ||| S:1378 E:1390 ||| RB
;  ||| S:1390 E:1392 ||| :
p    ||| S:1392 E:1394 ||| CD
< ||| S:1394 E:1395 ||| SYM
.001 ||| S:1396 E:1400 ||| CD
) ||| S:1400 E:1401 ||| -RRB-
.  ||| S:1401 E:1403 ||| .
Context-specific  ||| S:1403 E:1420 ||| NNP
and  ||| S:1420 E:1424 ||| CC
culturally  ||| S:1424 E:1435 ||| JJ
appropriate  ||| S:1435 E:1447 ||| JJ
HIV  ||| S:1447 E:1451 ||| NNP
stigma-reduction  ||| S:1451 E:1468 ||| JJ
interventions  ||| S:1468 E:1482 ||| NNS
in  ||| S:1482 E:1485 ||| IN
low-HIV  ||| S:1485 E:1493 ||| JJ
prevalence  ||| S:1493 E:1504 ||| JJ
settings  ||| S:1504 E:1513 ||| NNS
can  ||| S:1513 E:1517 ||| MD
reduce  ||| S:1517 E:1524 ||| VB
fear-based  ||| S:1524 E:1535 ||| JJ
and  ||| S:1535 E:1539 ||| CC
value-based  ||| S:1539 E:1551 ||| JJ
stigma  ||| S:1551 E:1558 ||| NN
among  ||| S:1558 E:1564 ||| IN
physicians  ||| S:1564 E:1575 ||| NNS
and  ||| S:1575 E:1579 ||| CC
nurses ||| S:1579 E:1585 ||| NNS
.  ||| S:1585 E:1587 ||| .
